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Franziska Hempel1* and Uwe G Maier1,2Abstract
Background: Although there are many different expression systems for recombinant production of pharmaceutical
proteins, many of these suffer from drawbacks such as yield, cost, complexity of purification, and possible
contamination with human pathogens. Microalgae have enormous potential for diverse biotechnological
applications and currently attract much attention in the biofuel sector. Still underestimated, though, is the idea of
using microalgae as solar-fueled expression system for the production of recombinant proteins.
Results: In this study, we show for the first time that completely assembled and functional human IgG antibodies
can not only be expressed to high levels in algal systems, but also secreted very efficiently into the culture medium.
We engineered the diatom Phaeodactylum tricornutum to synthesize and secrete a human IgG antibody against the
Hepatitis B Virus surface protein. As the diatom P. tricornutum is not known to naturally secrete many endogenous
proteins, the secreted antibodies are already very pure making extensive purification steps redundant and
production extremely cost efficient.
Conclusions: Microalgae combine rapid growth rates with all the advantages of eukaryotic expression systems, and
offer great potential for solar-powered, low cost production of pharmaceutical proteins.
Keywords: Diatoms, Expression system, IgG antibody, Protein secretionBackground
Microalgae are of great ecological importance as they rep-
resent a major source of global oxygen and contribute
critically to carbon fixation [1,2]. But also in biotechnical
applications microalgae offer enormous potential and have
been used in food and cosmetic industry already for many
years now as certain species represent a natural source of
omega-3-fatty acids, vitamins, pigments and anti-oxidants.
Especially within the last decade microalgae came into
focus of fuel industry as a renewable and beneficial source
of lipid interesting for biodiesel production [3-5].
Another aspect of algal biotechnology is the idea of
using microalgae as expression systems for recombinant
proteins [6-9]. No matter if enzymes, hormones, anti-
bodies or biotechnological relevant protein compounds –
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distribution, and reproduction in any mediumespecially in medical and industrial sectors [10]. Classical
expression systems like bacteria, yeast or mammalian cell
cultures all depend on external carbon sources emerging
as an important cost factor in large-scale expression.
Microalgae combine various advantages of classical ex-
pression systems as they possess rapid growth rates, are
very easy to handle, provide eukaryotic post-translational
modifications and are no host to human pathogens. Add-
itionally, microalgae are fueled by photosynthesis and
work CO2-neutral making them very interesting as low-
cost environment friendly protein factories [11-13].
Research in that field focused so far mainly on the green
alga Chlamydomonas reinhardtii demonstrating that
medical relevant proteins like antibodies, hormones and
vaccines can be produced very efficiently in the chloro-
plast of the cells [14-18]. Recent work revealed that other
species like the diatom Phaeodactylum tricornutum can
express foreign proteins with high efficiency also from nu-
clear promoters having the advantage that even complex
eukaryotic proteins can be synthesized, which need post-entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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subunits. A fully-assembled and functional human IgG
antibody against the Hepatitis B Virus surface protein
(HBsAg) was shown to accumulate in P. tricornutum to
9% of total soluble protein [19]. Furthermore, the intro-
duction of the bacterial PHB-pathway led to efficient
production of the bioplastic poly-3-hydroxybutyrate
(PHB) demonstrating that algae might represent an
production platform not only for proteins but also
other bioproducts [20].
Efficient protein expression is an important issue, but
before ending up with the final product time consuming
and extensive processing steps such as cell harvesting,
cell lysis followed by product purification are usually ne-
cessary. Hence, the ideal expression system does not
only produce recombinant proteins with high efficiency
but also secrets the proteins into the medium making
many cost-intense purification steps dispensable. So far
research on protein secretion in microalgae is very rare,
but in cell wall deficient Chlamydomonas strains it was
already shown that protein secretion of foreign proteins
is basically possible even though efficiency seems to be
rather low [21]. In diatoms like P. tricornutum polysac-
charides are known to be secreted depending on culture
conditions and the morphotype [22], however, little is
known about protein secretion [23-25].
Here we show for the first time that a microalgal
system like the diatom P. tricornutum is able to se-
crete a fully assembled and functional human IgG
antibody with high efficiency into the medium. Thus,
this study highlights the great potential of these
microalgae as novel protein factories secreting com-
plex molecules, which remain functional within the
medium for several days.Figure 1 Analyses on antibody secretion by P. tricornutum. Light and
B Virus surface protein were expressed in P. tricornutum for two days either
the cellular fraction (c) and the cell-free medium (m) were subsequently se
Coomassie/Silver Staining. In cells expressing an ER-retention signal hardly
retention signal leads to efficient antibody secretion. Under non-reduced c
assembled antibody (consisting of two heavy and two light chains) is dete
of 15 ml/30 ml cell-free medium were concentrated and precipitated. 10 μResults
Expression and secretion of a human IgG antibody by the
diatom P. tricornutum
Based on our previous studies on antibody expression in
the ER of P. tricornutum [19], we now expressed the
human IgG antibody against the Hepatitis B Virus sur-
face protein (CL4mAb) without the ER retention signal
(DDEL) at the C-terminus of both antibody chains.
Amazingly, this modification led to secretion of the fully
assembled antibody across the frustule of the diatom
and completely functional antibodies accumulated to
very high amounts directly in the media.
For initial analyses on antibody secretion, expression
of recombinant proteins was induced for two days. Sub-
sequently, cells were harvested and the supernatant was
filtered to remove any remaining cells. Proteins of the
cell-free medium were then concentrated, precipitated
and analyzed by gel electrophoresis. Western Blot ana-
lyses as well as Coomassie Staining of the gel demon-
strated that heavy and light chains are both present in
the medium in high quantities and purity as hardly any
other proteins were detected even after Silver Staining
(Figure 1). In comparison, cells expressing the antibody
with an ER-retention signal showed only very low
amounts of antibody in the medium (Figure 1). To check
in a first approach whether secreted heavy and light
chains are assembled in a complex, samples were pre-
pared under non-reduced conditions followed by gel
electrophoresis. Western Blot analyses revealed that in-
deed both chains are no longer detected separately but
result in a high molecular weight signal of about 170
kDa (Figure 1), which corresponds to a fully-assembled
IgG complex consisting of two heavy and two light
chains that are connected via disulfide bridges.heavy chain of the human IgG antibody CL4mAb against the Hepatitis
with (+DDEL) or without an ER-retention signal (−DDEL). Proteins of
parated by gel electrophoresis and analyzed by Western Blot and
any antibody is detected in the medium, whereas the deletion of the
onditions a high molecular weight signal corresponding to the fully
cted. For Western Blot analyses/Coomassie and Silver Staining proteins
g protein of the cellular fractions was loaded.
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was tested for antibody secretion to see whether secre-
tion is a rare exception occurring accidentally in some
cell lines or whether antibody secretion occurs routinely
with differences in secretion efficiency. In a small scale
screening twelve independent cell lines were cultivated
under non-induced conditions until reaching a density
of about 0.2 (OD600). Subsequently, cells were trans-
ferred to nitrate containing medium for two days and
proteins of the cell-free medium were concentrated, pre-
cipitated and used for subsequent Western Blot analyses.
Except for one cell line, which did not produce detect-
able antibody levels, all other cell lines tested expressed
and secreted the antibody with varying efficiency
(Figure 2). Western Blot analyses with an antibody
against α-tubulin demonstrate additionally that the
medium is free of intracellular proteins, which could
have been a result of broken cells. Hence, the detected
antibody in the medium is exclusively a result of se-
cretion. In the following, four cell lines with high se-
cretion efficiency (#3, #8, #11 and #12) were selected
for broader analyses on functionality and quantification
of the secreted antibody.
Quality and quantity of secreted antibodies
Western Blot analyses with non-reduced samples of the
secreted antibodies gave first indications that indeed
fully-assembled antibodies and not only separate anti-
body chains are secreted by P. tricornutum (Figure 1).
Most important, however, is of course the question
whether i) the secreted antibodies are functional, i.e. are
able to recognize the respective target antigen, and ii)
the algal expression system can provide secreted anti-
bodies in amounts that are economically interesting.
Hence, to check quality and quantity of the secreted
antibodies, samples of the medium were taken over a
time of five days and analysed by ELISA as well as quan-
tification assays (Figure 3). ELISA analyses demonstratedFigure 2 Comparison of antibody secretion efficiency of different P. t
independent transfectants were tested for antibody expression and secreti
cellular fraction (c) and the cell-free medium (m) were precipitated and sep
for cell line #4 all transfectants express the antibody and secrete it efficient
broader analyses on antibody functionality and quantity. As a loading cont
contaminated with intracellular proteins of destroyed cells an antibody aga
protein of 15 ml cell-free medium were loaded.that the secreted antibodies are indeed functional and
recognize the target, the Hepatitis B Virus surface anti-
gen (HBsAg), whereupon binding efficiency basically
correlated with the amount of antibodies measured
in the medium. The amount of secreted antibodies
increased over the first two days of expression (T1,T2)
to 450–850 ng antibody per ml medium being
reflected in an increased binding efficiency in the
ELISA assays as well (Figure 3). After two days the
amount of antibody and also binding efficiency slightly
decreased, which might be due to degradation in com-
bination with low nitrate levels impairing expression of
fresh antibody from the nitrate-inducible promoter,
however, by exchanging the medium, and thereby giv-
ing a fresh source of nitrate (T0*), antibody expression
could be enhanced again and culminated after two
days with impressive levels of 1550–2550 ng/ml depend-
ing on the cell line tested (Figure 3). Altogether, one can
conclude from the data that antibody levels in the
medium correlate with the density of the cultures as at
later time points T1* and T2* with a culture density of
1.4- 1.6 in cell line #11 antibody amounts are much
higher compared to time points T1 and T2. Two days
turned out to be an optimal induction period for anti-
body expression with highest secretion efficiency. The
antibody containing medium can then be harvested and
replaced with fresh nitrate-medium making a continuous
cultivation strategy feasible and very attractive.
Discussion
Classical expression systems for recombinant proteins like
bacteria and yeast have been engineered to produce pro-
teins with high efficiency, however, there are still many
drawbacks when expressing complex eukaryotic proteins
needing posttranslational modifications or the assembly
of multiple protein units. Mammalian systems represent
an alternative and are today used for 60–70% of recom-
binant protein pharmaceuticals, however cultivation isricornutum transfectants. In a small scale screening twelve
on efficiency after two days of protein expression. Proteins of the
arated by SDS-PAGE. Western Blot analyses demonstrate that except
ly into the medium. Cell lines #3, #8, #11 and #12 were selected four
rol for cellular proteins and to check that the medium is not
inst α-tubulin was used. 10 μg protein of the cellular fraction and
Figure 3 Analyses on functionality and quantity of secreted antibodies in four independent cell lines. Antibody expression in cell lines #3,
#8, #11 and #12 was induced at time point T0 with a culture density of 0.65. Subsequently, samples of the medium were taken over three days
(T1, T2, T3) followed by a medium exchange (T0*) and two additional days of sampling (T1*, T2*). Functionality of the antibody, i.e. the efficiency
of the antibody to bind to its antigen, was measured by ELISA assays. The secreted antibody binds to the antigen with an efficiency that basically
correlates with the antibody amounts measured in the samples. During the first two days antibody quantities within the medium increased to
concentrations of 450–850 ng/ml. After day two the amount of antibody in the medium slightly decreased, which is consequently accompanied
by a loss in binding efficiency. The removal of the antibody containing medium and addition of fresh nitrate-containing medium restored
antibody expression/secretion and resulted in antibody concentrations of 1550–2550 ng/ml at day T2* depending on the cell line tested. Error
bars indicate standard deviation (n = 3).
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pathogenic contaminations [26].
Pioneer projects have shown that microalgae per-
form very well in producing recombinant proteins
with the advantage that no external carbon source is
needed, which is an important cost factor when large
scale production is intended. Microalgae combine
rapid growth rates with all advantages of eukaryotic
expression systems. Furthermore, many microalgae
provide valuable side products interesting for biofuel
industry as well as for food and cosmetic sectors
[27-30] making microalgae an attractive platform for
the production of recombinant proteins.
Monoclonal antibodies belong to one of the largest
categories of biotechnologically produced pharmaceu-
ticals today and are needed in diagnostics as well as
in therapeutic applications with tumor therapy as a
promising novel field of application [31,32]. Many dif-
ferent expression systems were tested over the last 20
years, however, mammalian systems still represent the
first choice [33-35]. In previous studies we have
shown that a human IgG antibody against the Hepa-
titis B Virus surface protein can be produced very
efficiently in the diatom P. tricornutum accumulating
to about 9% of total soluble protein. Our data pre-
sented here demonstrate additionally that the diatom
is able to secrete these antibodies efficiently into the
medium. The secreted antibodies are fully-assembled
and functional in ELISA and accumulate in the
medium to up to 2.5 μg/ml. From an economical
point of view the secretion of recombinant proteins
into the culture medium is of course an enormous ad-
vantage since many processing steps like cell harvesting
and lysis are redundant. Because the diatom is not
known to secrete many proteins by natural means, theantibodies in the medium are already very pure as con-
firmed by Coomassie/Silver Staining of precipitated
proteins from the medium (Figure 1).
In our studies we have used a nitrate-inducible pro-
moter system, which has the advantage that antibody
production is tightly controlled and best induction
periods for highest production efficiency with best
functionality can be identified. Secretion efficiency in
P. tricornutum turned out to be highest after 2 days
of protein expression with a culture density of 1.0 -
1.6 (OD600). The antibodies remained stable within
the medium for at least two days before showing a
slight decrease in functionality and quantity. Exchan-
ging the culture medium demonstrates that product-
ivity of the cells can be restored when providing
fresh nitrate, vitamins etc., hence, a continuous culti-
vation model seems to be very attractive with the
antibody containing medium being harvested and
replaced by fresh nitrate-containing medium every
two days.
The cell lines used in the presented study have so
far been shown to be stable for two years, but when
stored probably clones should be stable for many
years as known from other P. tricornutum transfec-
tants tested in previous studies. First indications sug-
gest additionally that only completely assembled
antibodies can get secreted by P. tricornutum but no
heavy chains or heavy chain dimers (data not shown).
Interestingly, this alga seems to have mechanisms
similar to mammalian cells to guarantee that heavy
chains leave the cell only in association with light
chains - “virtually acting like a human plasma cell”.
In mammalian cells this is known to be mediated by
a stable association with BiP until light chains get
bound [36].
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This study highlights the enormous potential of microal-
gae as solar-fueled expression system for recombinant
proteins. Even complex pharmaceutical molecules like
completely assembled and functional IgG antibodies can
not only be produced in an algal system but also
secreted very efficiently into the culture medium. This
massively eases downstream purification steps being al-
ways problematic and cost-intensive in recombinant
protein production. Of course the algal system can
presently not compete with mammalian systems that
have been engineered to produce high amounts of
antibodies with transient expression levels for recom-
binant antibodies of 100–1000 mg/l [35]. Nevertheless,
this pilot projects highlights the great potential of
microalgal expression systems, and in future expression
of other antibodies as well as production and secretion
performance will be optimized. Cells might also be
engineered to allow human specific modifications such
as specific glycosylation patterns, which was already
shown to be feasible in plant systems [37-41] and
would broaden the application spectra significantly.
Methods
Plasmid construction and P. tricornutum transfection
DNA sequences for light and heavy chain of the mono-
clonal IgG1/kappa antibody CL4mAb were adapted to
P. tricornutum specific codon usage (GenBank accession
numbers: JF970211, JF970210) and cloned into the plas-
mid pPha-DUAL[2xNR] (JN180664), which contains two
multiple cloning sites both under control of the nitrate
reductase promoter/terminator system of P. tricornutum.
Variants with and without an ER retention signal
(DDEL) at the C-terminus were generated and intro-
duced into P. tricornutum as described previously
[19,42].
Cell culture and analyses on antibody secretion
Cells were cultivated under continuous illumination (80
μmol photons per m2 per s) either on plates containing
solid f/2-medium with 1.3% agar or in liquid culture
with constant agitation (150 rpm) as described previ-
ously [19]. For analyses on antibody secretion cells were
grown in 50–500 ml f/2 medium with 1.5 mM NH4Cl to
a density of 0.2-0.7 (OD600). Subsequently, cells were
harvested (1500 x g, 10 min) and transferred to fresh
medium containing 0.9 mM NaNO3 to induce antibody
production. For initial analyses on antibody secretion
and screening for cell lines with highest secretion effi-
ciency cultures were adjusted to the same density
(OD600 = 0.2) and samples were taken after 2 days of
antibody expression. Cells were removed by centrifuga-
tion and the medium was filtrated (pore size 0.2 μm)
and then concentrated with centrifugal filter columns(cut off 10 kDa). For checking on antibody assembly by
SDS-PAGE no β-mercaptoethanol was added to the
sample buffer (non-reducing conditions). For broader
analyses on production efficiency and antibody func-
tionality over time 1 ml samples were taken after differ-
ent time points, the medium was filtered and stored at
−80°C before proceeding with antibody quantification
and functionality analyses.
Antibody quantification and ELISA
For quantification of the secreted antibody the Easy-
Titer Human IgG (H+L) assay kit (ThermoScientific)
was used. The filtrated medium was diluted 1:2–1:8 and
antibody concentrations were measured according to
manufacturer´s instructions with human IgG as standard
(550–17.2 ng/ml). Functionality of the secreted antibody
was assayed by ELISA. Plates were coated with 200 ng of
Hepatitis B Virus surface antigen (HBsAg subtype adr,
Abcam) over night as described previously [19]. After
blocking and subsequent washing steps, the wells were
incubated with the filtrated medium (1:20 dilution in
PBS) for 3h. Antibody bound to the HBsAg was detected
with an anti-human IgG secondary antibody coupled to
HRP (Sigma-Aldrich). Medium of wild type cells and
non-induced cultures served as a negative control in
both assays. All measurements were carried out in triple.
Abbreviations
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